JPMorgan Chase & Co’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $304K | Buy |
10,361
+2,310
| +29% | +$67.7K | ﹤0.01% | 4272 |
|
|
2025
Q1 | $207K | Sell |
8,051
-291
| -3% | -$7.48K | ﹤0.01% | 4421 |
|
|
2024
Q4 | $241K | Buy |
8,342
+2,643
| +46% | +$76.3K | ﹤0.01% | 4464 |
|
|
2024
Q3 | $135K | Buy |
5,699
+279
| +5% | +$6.62K | ﹤0.01% | 4617 |
|
|
2024
Q2 | $93.7K | Buy |
5,420
+3,738
| +222% | +$64.6K | ﹤0.01% | 4621 |
|
|
2024
Q1 | $37.6K | Sell |
1,682
-913
| -35% | -$20.4K | ﹤0.01% | 5063 |
|
|
2023
Q4 | $47.6K | Sell |
2,595
-1,504
| -37% | -$27.6K | ﹤0.01% | 5024 |
|
|
2023
Q3 | $71.2K | Buy |
4,099
+691
| +20% | +$12K | ﹤0.01% | 4787 |
|
|
2023
Q2 | $62K | Buy |
3,408
+3,198
| +1,523% | +$58.2K | ﹤0.01% | 4811 |
|
|
2023
Q1 | $4K | Sell |
210
-349
| -62% | -$6.65K | ﹤0.01% | 5447 |
|
|
2022
Q4 | $13K | Sell |
559
-337
| -38% | -$7.84K | ﹤0.01% | 5063 |
|
|
2022
Q3 | $20K | Buy |
896
+175
| +24% | +$3.91K | ﹤0.01% | 4932 |
|
|
2022
Q2 | $14K | Sell |
721
-2,211
| -75% | -$42.9K | ﹤0.01% | 5128 |
|
|
2022
Q1 | $105K | Buy |
2,932
+1,311
| +81% | +$46.9K | ﹤0.01% | 4722 |
|
|
2021
Q4 | $141K | Buy |
1,621
+732
| +82% | +$63.7K | ﹤0.01% | 4695 |
|
|
2021
Q3 | $102K | Buy |
+889
| New | +$102K | ﹤0.01% | 4705 |
|